Article
Xanthogranulomatous Reaction to Trametinib for Metastatic Malignant Melanoma
- Author:
- Michelle S. Min, MD, MSci
- Jonathan Yao, MD
- Nicole Chee
- Allen N. Sapadin, MD
- Helen Shim-Chang, MD
Trametinib, a mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor, has demonstrated great promise in...